Harmonisation panel makes progress on CTD
International Conference on Harmonisation committee reports
progress being made on a number of fronts, including the common
InnaPhase completes Beckman LAO buy
InnaPhase has completed the transaction of Beckman Coulter's
Laboratory Automation Operations (LAO) that was announced in May of
LGC expands pharma business outside UK
LGC has acquired Germany's Mikromol, a specialist in pharmaceutical
impurities and metabolites used as reference materials, to create
its first non-UK lab.
Baxter accuses former employee of espionage
Baxter has filed a lawsuit in the USA alleging that one of its
former employees provided proprietary manufacturing information to
rival company Bayer.
A new whey for pharma-grade lactose
Australian dairy farmers could become major suppliers of
pharmaceutical-grade lactose, if a new technology developed at the
Commonwealth Scientific and Industrial Research Organisation can be
Production starts at Abu Dhabi's Neo Pharma
Neo Pharma becomes the first company to start manufacturing
pharmaceuticals in Abu Dhabi. The company's facility offers both
production and R&D capabilities.
Gentler risedronate forms patented by P&G
Procter & Gamble has patented a new formulation of risedronate
that overcomes the upper gastrointestinal side effects that can
occur with the osteoporosis drug.
Tecan takes comfort from stronger second quarter
Tecan second-quarter results reveal some signs of recovery after a
torrid first quarter and the departure of former chief executive
Emile Sutcliffe, with diagnostics holding back an improved
performance in biopharma.
Roche in talks to buy Igen?
Roche is said to be considering a purchase of diagnostics company
Igen International after a US appeals court ruling put a slice of
the Swiss group's diagnostics operations in jeopardy.
Genome on a chip from Applied Bio
Applied Biosystems has unveiled a gene expression analysis product
that allows researchers to conduct studies on the entire human
genome using a single microarray.
Novel psychiatric drugs licensed by Abiogen
Italy's Abiogen Pharma has licensed rights to two UK-developed
compounds that seem to work via a completely new mechanism of
action for the treatment of anxiety.
Pharma's focus on growth "unsustainable" says report
The pharmaceutical industry is failing to increase efficiencies in
core areas of its business - such as clinical trials and sales -
because of an enormous pressure from investors to drive revenues,
according to Datamonitor.
PIERIS expands IP in Anticalins
PIERIS has strengthened its patent estate for a new class of
proteins which could represent a more flexible alternative to
Lonza revamp comes too late for first-half figures
The difficulties facing Lonza came into clear focus today as the
company published its half-year results, with sales down across its
custom manufacturing, organic chemicals and polymers businesses.
Emisphere tech aids oral protein delivery
Emisphere Technologies has demonstrated effective oral delivery of
protein-based drugs in three studies presented at the Controlled
Release Society's annual meeting.